Intraperitoneal Immune Checkpoint Inhibitors and Zoledronic Acids for Gastric Cancer Malignant Ascites

NCT06759064 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Stomach, Adenocarcinoma
Ascites, Malignant

Interventions

DRUG: zoledronic acid plus Sintilimab intraperitoneal injection

Sponsor

Qilu Hospital of Shandong University